Charles River Laboratories
396 hedge funds and large institutions have $6.19B invested in Charles River Laboratories in 2019 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 147 increasing their positions, 142 reducing their positions, and 42 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
1.16% more ownership
Funds ownership: 95.81% → 96.97% (+1.2%)
6% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $10.5M
4% more repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 142
2% less funds holding
Funds holding: 405 → 396 (-9)
7% less capital invested
Capital invested by funds: $6.63B → $6.19B (-$441M)
14% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$89.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$27.2M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$26.8M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$24.6M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$22.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$51.2M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$46.6M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$31.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$28.4M |
| 5 |
Renaissance Technologies
New York
|
-$27.9M |
CRL Hedge Fund Activity: Q3 2019 in Review
396 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2019, worth a combined $6.19B — down 6.7% from $6.63B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of CRL and 36 opened new positions — a net loss of 6 holders — while 142 trimmed existing stakes and 147 added.
The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $89.5M. The largest seller was Millennium Management, cutting an estimated $51.2M.
- 396 institutional investors held Charles River Laboratories (CRL) as of Q3 2019, down from 405 in Q2 2019.
- Funds reported $6.19B of Charles River Laboratories stock for Q3 2019, down 6.7% quarter-over-quarter.
- 36 funds opened new Charles River Laboratories positions in Q3 2019 and 42 closed out, a net change of -6 holders.
- The largest Charles River Laboratories buyer in Q3 2019 was Kayne Anderson Rudnick Investment Management, an estimated $89.5M added.
- The largest Charles River Laboratories seller in Q3 2019 was Millennium Management, an estimated $51.2M sold.
Based on aggregated 13F filings for Q3 2019.